Eurofins

Eurofins Scientific

Type	Public (Euronext: ERF)
Industry	Laboratory analysis
Founded	1987
Founder	Gilles Martin
Revenue	EUR 2.54 billion (2017)
Number of employees	>30,000 (2017)
Website	www.eurofins.com

Eurofins is an international group of laboratories headquartered in Luxembourg, providing testing and support services to the pharmaceutical, food, environmental and consumer products industries and to governments. Eurofins employs more than 30,000 employees across around 375 laboratories in 41 countries and has about EUR 2.54 billion annual revenues (2017).

The Eurofins Group offers a portfolio of over 130,000 reliable analytical methods for characterizing the safety, identity, purity, composition, authenticity and origin of products and biological substances. Through research and development, in-licensing and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical sciences.

Eurofins pursued an aggressive strategy of expansion, buying more than eighty competitors worldwide since it was founded. Notable examples include the acquisition in 2005 of the German company MWG-Biotech and in 2011 of the US company Lancaster Laboratories the latter being acquired for 150 million euros.

In May 2015, Eurofins acquired QC Laboratories in the US and Experchems in Canada as part of its American expansion strategy. In June 2015, Eurofins announced the acquisition of Biomnis in France for 220 million euros.

The company has developed an exclusive method of food analysis, testing and authentication that has thwarted the counterfeiting of food goods, and also cigars. The company's testing can also detect food contaminants.